Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Cash from Financing Activities (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Cash from Financing Activities data on record, last reported at $268829.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 368.54% year-over-year to $268829.0; the TTM value through Sep 2025 reached $269108.0, up 211.34%, while the annual FY2024 figure was -$189389.0, 151.25% down from the prior year.
  • Cash from Financing Activities reached $268829.0 in Q3 2025 per HYEX's latest filing, up from $83782.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $846880.0 in Q1 2021 and bottomed at -$108166.0 in Q2 2024.
  • Average Cash from Financing Activities over 5 years is $98907.1, with a median of $49146.0 recorded in 2024.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 3755.28% in 2023, then plummeted 559.83% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $77199.0 in 2021, then skyrocketed by 79.7% to $138730.0 in 2022, then crashed by 159.52% to -$82574.0 in 2023, then skyrocketed by 63.35% to -$30260.0 in 2024, then surged by 988.4% to $268829.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $268829.0 in Q3 2025, $83782.0 in Q2 2025, and -$53243.0 in Q1 2025.